Connect with us

Global Health

Ethical Issues With Uterus Transplantation Same As In Altruistic Surrogacy (VIDEO)

Uterus transplantation and altruistic surrogacy face the same ethical issues



uterus transplantation and altruistic surrogacy
Uterus transplantation and altruistic surrogacy. Photo Credit: Geralt/Pixabay
Press Release

The first child to be conceived and gestated inside a donated uterus was born in 2014. Ten other children have been birthed in transplanted uteruses since then. Eight of these were born in Sweden, prompting further research projects into the sustainability of uterus transplantation. But this medical feat is not without its inherent problems, at least in the ethical sense.

Researchers from Linköping University found that the problems associated with uterus transplantation are more ethical than medical. And they found that ethical issues connected with donated uteruses are as problematic as ethical issues connected with altruistic surrogacy – especially since these involve living donors.

Lisa Guntram, researcher at Linköping University, revealed that the study was not to establish the medical possibilities of uterus transplantation. But to get people to be conscious of its parallels with altruistic surrogacy, especially where ethics are concerned. Guntram with Nicola Jane Williams from Lancaster University in the UK published their findings in the journal Bioethics.

A 2016 Swedish white paper advocated that altruistic surrogacy must not be allowed in the Swedish primary healthcare system. Reviewing the arguments put forward in the paper, Guntram opined that the Swedish people could be more open to uterus transplantation than they are to altruistic surrogacy. Uterus transplantation and altruistic surrogacy are both solutions to childlessness.

But they are both confronted with the following arguments among others:

  • Whether the donors were not pressurized to offer their help

Relatives and elderly mothers were often the donors of uteruses in Sweden. It is argued that mothers and relatives of childless women may have been forced to donate their uteruses by circumstances one way or the other. Surrogate mothers were also believed to have faced some level of external pressure before they agree to intervene on behalf of the childless couple. This constitutes an ethical issue.

  • Whether donors do it for monetary benefits in what could blosom into an organ trade

Where surrogacy is concerned, there are underlying fears that surrogate mothers may have accepted monetary compensations to help. There is also the fear that if people are paid to donate their uterus, black market for organ trade could soon develop where kidneys and lungs among other internal organs are sold for transplantation. This is not to mention the fact that both surrogacy and uterus transplantation could constitute an exploitation of women’s bodies.

  • Whether there are enough physical and psychological protections for children born from such interventions

Since only ten or so children have been born from uterus transplantation, little is known of the consequences of such birth on development. The same is true with altruistic surrogacy. So further research is required to understand the effects of such birth on children born that way.

Finally, the authors of the study conclude that uterus transplantation and altruistic surrogacy face almost the same ethical issues in Sweden and possibly anywhere else.

This post was originally published on Health News Office

Fisayo is a seasoned writer, online entrepreneur and accredited website designer/developer. He currently writes for HNO and is the brain behind managing the site. He can be reached at [email protected]

Global Health

Lewy Body Dementia Treatment Centers is Booming Worldwide with Top Key Players



Press Release

Global Lewy Body Dementia Treatment Market- A report by Fact.MR

Fact.MR, in its latest business intelligence study, depicts the nuts and bolts of the global lewy body dementia treatment centers. The lewy body dementia treatment market report presents detailed information regarding the drivers, restraints, opportunities and trends affecting market growth. Each segment along with its sub-segment is analyzed in terms of value and volume. Further, the keyword report elaborates the market behavior of each vendor operating in the lewy body dementia treatment market.

The lewy body dementia treatment market considers the following years to present the overall market growth:

  • History Year: 2013 – 2017
  • Base Year: 2013
  • Estimated Year: 2028
  • Forecast Year: 2018 – 2028

Key findings of the lewy body dementia treatment market study:

  • Regional breakdown of the keyword market based on predefined taxonomy.
  • Innovative manufacturing processes implemented by keyword vendors in detail.
  • Region-wise and country-wise fragmentation of the keyword market to grasp the revenue, and growth outlook in these areas.
  • Changing preferences among consumers across various regions and countries.
  • Factors (Positive and Negative) impacting the growth of the global keyword market.

On the basis of Drug Type, the lewy body dementia treatment market study consists of:

  • Cholinesterase Inhibitors
  • Antipsychotic Drugs
  • Carbidopa-Levodopa
  • Antidepressants
  • Benzodiazepine
  • Modafinil

On the basis of Distribution Channel, the lewy body dementia treatment market study incorporates:

  • Online Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • Hospital Pharmacies

For a detailed industry outlook, Get the Report Sample at:

On the basis of region, the lewy body dementia treatment market study contains:

  • North America (U.S., Canada)
  • Europe (U.K., Germany)
  • Latin America (Brazil, Mexico)
  • South Asia (Thailand, Indonesia)

Key players analyzed in the lewy body dementia treatment market study:

  • BioArctic AB
  • Eisai Co., Ltd.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Jazz Pharmaceuticals, Inc.
  • Immungenetics AG
  • Noven Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • Novartis AG
  • Pfizer Inc.
  • Bayer AG
  • Mylan NV
  • Sanofi AG
  • Teva Pharmaceutical Industries Limited
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited

Queries addressed in the lewy body dementia treatment market report:

  • How has the global lewy body dementia treatment market grown over the historic period of 2013-2017?
  • Why are the lewy body dementia treatment market players targeting region for increased product sales?
  • What patented technologies are the players utilizing in the global lewy body dementia treatment market?
  • Which regions are displaying the fastest growth in the lewy body dementia treatment market?
  • What are the underlying micro- macroeconomic factors affecting the global lewy body dementia treatment market?

Request for Report Methodology:

Why choose Fact.MR?

Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.

This post was originally published on Health News Office

Continue Reading

General Health

DNA Chip Market Set to Garner Staggering Revenues by 2023



Press Release

The global DNA Chip Market rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for DNA Chip are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the DNA Chip Market that is critical for defining your success strategy. It offers prudent information on market’s under currents, trends that will open new doors, factors that will remain important, challenges that need to be overcome, prevailing competition in the market, and the geographical landscape.

Based on a tested and proven research methodology, our research analysts bring to you fact-checked information. Besides presenting the current market figures, our analysts provide you with accurate forecasts that can be the game-changer for your winning strategies for tomorrow. On the other hand, our reports also offer tailor-made insights. Further, our reports are packed with experts’ viewpoints which are transcribed from interviews conducted by our analysts.

For every market, information on leading players can be the difference between success and failure, be it a prominent brand or not. Our reports cover every significant players in the global DNA Chip Market providing information about the company profile, products, winning strategies and market revenues. Not just that, TMR also provides information on the competitive landscape, helping you understand what impacted in one company being the market leader and others not. It also explains on the companies’ imperatives that define their success in the global market for DNA Chip.

To obtain all-inclusive information on forecast analysis of DNA Chip Market, Request a PDF Brochure Here

Healthcare, unlike most industries, is typical of the region. Humans have multiple races and hence their genetic makeups are different. As a result, one condition has different impacts depending on the region. Therefore, information on how consumer requirements are different in regional landscape of the global DNA Chip Market is provided her in the report. Further, the economic capabilities of a country has a huge impact on healthcare infrastructure. TMR’s report analysis the current economic scenario and also brings to you information on affordability during the coming years.

From market share to region-specific strategies, the report covers it all. At the same time, players in the DNA Chip Market who are looking to expand might want to assess the potential of a prospective region. Our reports can provide you with custom-made insights for specific regions in the global DNA Chip Market. The geographical analysis also covers regions-specific factors that could turn out to be hurdle for growth in the coming years.

This post was originally published on Health News Office

Continue Reading

Global Health

Pyrogen Testing Market is anticipated to grow at a 11.0% CAGR Till 2030



Press Release

Get Sample Copy with TOC to understand the structure of the complete report

Global Pyrogen Testing Market is estimated to be over US$ 650 Million in 2018. It is anticipated to grow at a 11.0% CAGR from 2019 to 2030. Pyrogen is a substance that induces fever, once the drug has been administered in the body. The presence of a pyrogenic element in a drug composition is undesirable. Hence, certain tests are carried out to check whether a particular drug can cause the undesirable side-effect in the body. The endotoxins, which are secreted by bacteria, possess the ability to elevate the body temperature.

Few of the dominant manufacturers in the Pyrogen Testing market incorporates in the report are-

  • Charles River, Inc.
  • Ellab A/S, Inc.
  • Lonza, Ltd.
  • Merck KGaA, Inc.
  • Associates of Cape Cod, Inc.
  • GenScript, Inc.
  • Sanquin, Inc
  • bioMerieux SA, Inc.
  • WuXi PharmaTech (Cayman), Inc.
  • Wako, Inc.

The report analyze the historic data relevant to the Pyrogen Testing market growth, scope and opportunities in brief. It also provides the current and witness Pyrogen Testing market data. The study serves overall vital growing Pyrogen Testing opportunities and risk/threats to the industry. It includes the technical development, Pyrogen Testing import/export scheme, estimated growth, product launch events, collabrations & acquisitions. Furthermore, report segregate market- based on Pyrogen Testing manufacturers, countries, applications and types.

Some of the major objectives of this report:

1) To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Pyrogen Testing Market.

  1. To provide insights about factors affecting the market growth. To analyze the Pyrogen Testing Market based on various factors- price analysis, supply chain analysis, porter five force analysis etc.
  2. To provide historical and forecast revenue of the Pyrogen Testing Market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World.
  3. Country level analysis of the market with respect to the current market size and future prospective.
  4. To provide country level analysis of the market for segment by application, product type and sub-segments.

Some Key points from TOC:

    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
      1. Secondary Sources
      2. Primary Sources
    4. Market Estimation Methodology
      1. Bottoms Up Approach
      2. Top Down Approach
    5. Data Validation and Triangulation
      1. Market Forecasting Model
      2. Limitations/Assumptions of the Study
      1. Overview
      2. Drivers
      3. Barriers/Challenges
      4. Opportunities

Two major factors are expected to boost the CAGR of the market in Asian countries like India and China. The ever-growing populations of these countries, and the demand for medicines owing to the high prevalence of chronic diseases in these regions, will drive the market. The key players in the market are already doing heavy investments in such countries. They are focusing on providing a number of products in their services. Increasing disposable income is another factor responsible for growth of the market. The Asia Pacific market is anticipated to reach a figure of US$ 270 Mn by 2020.

Pyrogen Testing Market Regional Coverage

In the regional analysis section, the report authors have shown how different regions and countries are growing in the Pyrogen Testing Market and have predicted their market sizes for the next few years.

  • The Middle East and Africa (GCC Countries and Egypt)
  • North America (the United States, Mexico, and Canada)
  • South America (Brazil etc.)
  • Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
  • Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand,  India, Indonesia, and Australia)

What does this report deliver?

  1. Comprehensive analysis of the global as well as regional markets of the Pyrogen Testing Market.
  2. Complete coverage of all the segments in the Pyrogen Testing Market to analyze the trends, developments in the global market and forecast of market size up to 2030.
  3. Comprehensive analysis of the companies operating in the global Pyrogen Testing Market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
  4. The growth matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Read More :—industry-trends-forecast-2019-to-2030-2019-08-14

Highlights of the Global Pyrogen Testing Market:

  1. What will the market size and the growth rate be in 2030?
  2. What are the key factors driving the Global Pyrogen Testing Market ?
  3. What are the key market trends impacting the growth of the market?
  4. What are the challenges to market growth?
  5. Who are the key vendors in the Global Pyrogen Testing Market ?
  6. What are the market opportunities and threats faced by the vendors in this market?

Buy Full Report

About Us

Market Industry Reports is a global leader in market measurement and advisory services. It is 100% subsidiary of Maniks Systems Pvt Ltd. The firm has always been at the forefront of innovation to address the worldwide industry trends and opportunities.

Contact Us- 

2nd Floor, Manikchand Ikon,

B-Wing, Dhole Patil Road,

Sangamwadi, Pune 411 001

Email: [email protected]
Phone: +1 347 767 5477 ( US )
+ 91 8956 767 535 ( IN )
Follow Us- LinkedIn | Twitter | Facebook


This post was originally published on Health News Office

Continue Reading